SAPC ASM 2020 - cancelled due to pandemic - Talk Abstracts

Back to SAPC ASM 2020 - cancelled due to pandemic

  1. S.1
    Impact of the frequency of advice to quit smoking and experience of care in general practice
  2. S.2
    Impact of persistent physical symptoms on the self: qualitative analysis of consultations and patient interviews.
  3. S.3
    How do transgender people experience their relationships with their GPs?
  4. S.4
    To what extent do patients and GPs have a shared understanding of blood testing in primary care?
  5. T.1
    What do patients want to improve in their own general practice? Adapting discrete choice experiments for local use.
  6. T.2
    Participatory evaluation of a co-designed intervention to strengthen patient involvement in improving general practice.
  7. T.3
    How do lay people experience their involvement in research?
  8. U.1
    The CHIPPS study: a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes
  9. U.10
    Prescribing of Long-term Antibiotic to Adolescents in Primary Care: a Retrospective Cohort Study
  10. U.11
    How can we optimise medication in older people on complex medication regimens living in the community?
  11. U.12
    Defining a medication review model for use in routine clinical practice
  12. U.13
    What are the associations between anticholinergic medication exposure and adverse health outcomes in older people living with frailty?
  13. U.14
    Public acceptance of delayed prescribing in UK primary care: a choice experiment
  14. U.15
    Patient characteristics associated with adverse drug reactions in older community-dwelling adults attending general practice: a prospective cohort study
  15. U.16
    Spatial Exploration of Deprivation Driven Inequalities in Opioids Prescribing in English Primary Care: a Cross Sectional Analysis
  16. U.17
    Do General Practitioners’ antibiotic prescribing decisions follow the STARWAVe clinical prediction rule?
  17. U.18
    Organisational variation and reliability of national polypharmacy performance indicators
  18. U.19
    The barriers to stopping inappropriate medicines (deprescribing): A patient and supporting peer perspective
  19. U.2
    Patient acceptability of a proposed clinical pharmacist-led review for persistent pain in primary care (PROMPPT study)
  20. U.20
    Determinants of Inappropriate opioid prescribing: A cross sectional study in a South London population

Pages